NCI/FDA Task Force Will Serve As Resource During Approval Process
This article was originally published in The Pink Sheet Daily
Executive Summary
NCI-funded investigators who reach an impasse in the regulatory process can utilize the "leadership group" of the FDA/NCI Interagency Oncology Task Force. The task force is converting its work into FDA guidance documents.
You may also be interested in...
Oncology Products Office Director Will Be "Appealing" Position
The position of Office of Oncology Drug Products director will be a "very appealing" job for oncology experts, Acting Commissioner Lester Crawford declared during his Aug. 2 luncheon address to the National Press Club
Oncology Products Office Director Will Be "Appealing" Position
The position of Office of Oncology Drug Products director will be a "very appealing" job for oncology experts, Acting Commissioner Lester Crawford declared during his Aug. 2 luncheon address to the National Press Club
FDA Will Conduct "National Search" For Head Of Oncology Office
The agency formally announces creation of an Office of Oncology Drug Products. The new director will oversee the consolidation of three areas within the Center for Drug Evaluation & Research currently responsible for cancer drug reviews.